I think that may be difficult considering the deal
Post# of 36537
(Total Views: 345)
Posted On: 09/14/2021 6:26:47 AM
I think that may be difficult considering the deals with China and Bintai Kinden. Having said that, any Covid rights will be increasingly valuable starting with an approved IND and moving through Phase1. Many deals are made upon successsful Phase 3.
If not, the team needs to be shaken up. At some point you have to realize after so many failures or things going sideways, somethining has to give.
The GNBT/NGIO team will hopefully bring this home and shareholders will see the financial reward. I personally will also take satisfaction in knowing I was a small part of helping the company and humanity.
We need to know about the IND and human trials.
If not, the team needs to be shaken up. At some point you have to realize after so many failures or things going sideways, somethining has to give.
The GNBT/NGIO team will hopefully bring this home and shareholders will see the financial reward. I personally will also take satisfaction in knowing I was a small part of helping the company and humanity.
We need to know about the IND and human trials.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼